Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InVitroCare is a private fertility products company focused on assisted reproductive technology (ART) media, sperm preparation products, embryo culture media, and related laboratory reagents and equipment used in IVF and IUI workflows. The company markets products for andrology and embryology laboratories, including sperm washing and freezing media, density gradient products, mineral oil, hyaluronidase, and embryo culture systems. Its portfolio is positioned as a commercial supplier to fertility clinics and physician offices rather than as a therapeutic drug developer. InVitroCare states that its products are manufactured in FDA-registered facilities and in compliance with QMS, GAMP 5, and ISO 13485 standards. The company appears to serve both U.S. and international ART customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InVitroCare.